|
|
|||||||||||||||||||||||||||
|
Corium International Inc (CORI) Corium International is a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products in transdermal and transmucosal delivery systems. Co. has several proprietary programs focusing primarily on the treatment of neurological disorders, with two lead programs in Alzheimer's disease. Co. has developed and is the manufacturer of seven prescription drug and consumer products for its marketing partners. Co. has two proprietary transdermal platforms: Corplex™ for small molecules and MicroCor®, a biodegradable microstructure technology for small molecules and biologics, including vaccines, peptides and proteins.
|
|
|||||||||||||||||||||||||||
Free CORI Email Alerts:
Corium International Inc (CORI) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.